An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases.

Significant advances have been made in the understanding of the genetics of retinitis pigmentosa (RP), a clinically and genetically heterogeneous group of disorders; and over 50 genes underlying ...

An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases.

Retinal proteome profiling of inherited retinal degeneration across three different mouse models suggests common drug targets in retinitis pigmentosa. Molecular & Cellular Proteomics , 2024 ...

Scientists could those save the sight of people suffering from age-related macular degeneration and retinitis by taking nerve cells from the leg and injecting them into the damaged area of the eye.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in ...

Andrew Nye has resigned as ARN’s Chief Financial Officer, effective immediately and with gardening leave for six months. James Marsh will act as CFO while a recruitment process takes place. ARN CEO ...

WWE Hall of Famer Arn Anderson is a known fan of WWE World Heavyweight Champion GUNTHER. And at WWE Bad Blood, which emanated from Atlanta, Georgia, he finally had an opportunity to tell "The Ring ...

ARN iHeart and Magellan AI have released their Top 15 Podcast Advertisers list for Q2 2024 as well as a new initiative to recognise the brands and agencies investing the most into the Australian ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...